Comparative effects of different types of exercise on health-related quality of life during and after active cancer treatment: A systematic review and network meta-analysis.
Cancer
Exercise
HRQoL
Physical activity
Journal
Journal of sport and health science
ISSN: 2213-2961
Titre abrégé: J Sport Health Sci
Pays: China
ID NLM: 101606001
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
12
07
2022
revised:
22
10
2022
accepted:
28
11
2022
medline:
6
11
2023
pubmed:
4
2
2023
entrez:
3
2
2023
Statut:
ppublish
Résumé
The positive influence of most types of exercise has been reported repeatedly, but what the most effective exercise approaches are for improving health-related quality of life (HRQoL) in people with cancer remains unknown. The aim of this systematic review and network meta-analysis was to synthesize the evidence from intervention studies to assess the effects of different types of exercise on HRQoL during and after cancer treatment. MEDLINE, SPORTDiscus, the Cochrane Library, Web of Science, and Scopus were searched for randomized controlled trials aimed at testing the effects of exercise interventions meant to improve HRQoL in people with cancer. Separate analyses were conducted for HRQoL as measured by general and cancer-specific questionnaires. We also evaluated whether the effects of exercise were different during and after cancer treatment in both the physical and mental HRQoL domains. In total, 93 studies involving 7435 people with cancer were included. Network effect size estimates comparing exercise intervention vs. usual care were significant for combined exercise (0.35, 95% confidence interval (95%CI): 0.14-0.56) for HRQoL as measured by general questionnaires, and for combined (0.31, 95%CI: 0.13-0.48), mind-body exercise (0.54, 95%CI: 0.18-0.89), and walking (0.39, 95%CI: 0.04-0.74) for HRQoL as measured by cancer-specific questionnaires. Exercise programs combining aerobic and resistance training can be recommended to improve HRQoL during and after cancer treatment. The scarcity and heterogeneity of these studies prevents us from making recommendations about other exercise modalities due to insufficient evidence.
Sections du résumé
BACKGROUND
The positive influence of most types of exercise has been reported repeatedly, but what the most effective exercise approaches are for improving health-related quality of life (HRQoL) in people with cancer remains unknown. The aim of this systematic review and network meta-analysis was to synthesize the evidence from intervention studies to assess the effects of different types of exercise on HRQoL during and after cancer treatment.
METHODS
MEDLINE, SPORTDiscus, the Cochrane Library, Web of Science, and Scopus were searched for randomized controlled trials aimed at testing the effects of exercise interventions meant to improve HRQoL in people with cancer. Separate analyses were conducted for HRQoL as measured by general and cancer-specific questionnaires. We also evaluated whether the effects of exercise were different during and after cancer treatment in both the physical and mental HRQoL domains.
RESULTS
In total, 93 studies involving 7435 people with cancer were included. Network effect size estimates comparing exercise intervention vs. usual care were significant for combined exercise (0.35, 95% confidence interval (95%CI): 0.14-0.56) for HRQoL as measured by general questionnaires, and for combined (0.31, 95%CI: 0.13-0.48), mind-body exercise (0.54, 95%CI: 0.18-0.89), and walking (0.39, 95%CI: 0.04-0.74) for HRQoL as measured by cancer-specific questionnaires.
CONCLUSION
Exercise programs combining aerobic and resistance training can be recommended to improve HRQoL during and after cancer treatment. The scarcity and heterogeneity of these studies prevents us from making recommendations about other exercise modalities due to insufficient evidence.
Identifiants
pubmed: 36736726
pii: S2095-2546(23)00003-0
doi: 10.1016/j.jshs.2023.01.002
pmc: PMC10658325
pii:
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
726-738Informations de copyright
Copyright © 2023. Production and hosting by Elsevier B.V.
Références
Prostate Cancer Prostatic Dis. 2013 Dec;16(4):328-35
pubmed: 23917308
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Ann Oncol. 2007 Dec;18(12):1957-62
pubmed: 17804476
Head Neck. 2004 Jun;26(6):518-30
pubmed: 15162353
Breast Cancer Res Treat. 2015 Jan;149(1):109-19
pubmed: 25417174
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390
pubmed: 31626055
CA Cancer J Clin. 2021 Mar;71(2):149-175
pubmed: 33107982
Psychooncology. 2009 Apr;18(4):343-52
pubmed: 19242918
Acta Oncol. 2014 Jan;53(1):65-74
pubmed: 23957716
Ann Oncol. 2001;12 Suppl 3:S3-6
pubmed: 11804381
Cancer. 2021 Oct 15;127(20):3856-3864
pubmed: 34161602
Eur J Cancer Care (Engl). 2013 Sep;22(5):626-37
pubmed: 23731173
BMC Pulm Med. 2014 Jul 28;14:121
pubmed: 25065540
PLoS One. 2017 Jul 20;12(7):e0181313
pubmed: 28727771
Cancer. 2008 Jul 1;113(1):214-22
pubmed: 18457329
Br J Sports Med. 2016 Jul;50(13):796-803
pubmed: 26719503
Cancer. 2015 Aug 1;121(15):2646-54
pubmed: 25877784
BJU Int. 2015 Feb;115(2):256-66
pubmed: 24467669
BMJ Open. 2019 Nov 3;9(11):e031374
pubmed: 31685509
Physiology (Bethesda). 2013 Sep;28(5):330-58
pubmed: 23997192
Cancer Nurs. 2005 Jul-Aug;28(4):301-9
pubmed: 16046894
Br J Surg. 2016 Apr;103(5):504-12
pubmed: 26864728
Blood. 2011 Mar 3;117(9):2604-13
pubmed: 21190995
Eur J Phys Rehabil Med. 2016 Aug;52(4):489-501
pubmed: 26761561
J Clin Oncol. 2009 Jan 20;27(3):344-51
pubmed: 19064985
Evid Based Complement Alternat Med. 2016;2016:5931816
pubmed: 27019663
Cancer Nurs. 2008 Mar-Apr;31(2):145-59
pubmed: 18490891
Int J Nurs Stud. 2017 Apr;69:25-33
pubmed: 28122280
J Cancer Surviv. 2020 Aug;14(4):424-433
pubmed: 32072434
Acta Oncol. 2014 Apr;53(4):510-20
pubmed: 24460069
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007566
pubmed: 22895961
Psychooncology. 2014 Mar;23(3):330-8
pubmed: 24123482
Int J Cancer. 2015 Jul 15;137(2):471-80
pubmed: 25484317
Int J Environ Res Public Health. 2020 Jul 10;17(14):
pubmed: 32664375
Acta Oncol. 2015 Nov;54(10):1805-13
pubmed: 25927504
Lung Cancer. 2011 Feb;71(2):229-34
pubmed: 20541832
J Cancer Surviv. 2016 Aug;10(4):633-44
pubmed: 26715587
PM R. 2017 Sep;9(9S2):S347-S384
pubmed: 28942909
Oncol Nurs Forum. 2010 Jan;37(1):E1-6
pubmed: 20044327
J Clin Epidemiol. 2014 Mar;67(3):267-77
pubmed: 24275499
Oncogene. 2016 Aug 4;35(31):4122-31
pubmed: 26686088
J Urol. 2022 Apr;207(4):814-822
pubmed: 35179044
J Clin Oncol. 2003 May 1;21(9):1660-8
pubmed: 12721239
Br J Sports Med. 2018 Apr;52(8):505-513
pubmed: 28954800
J Clin Epidemiol. 2016 Jul;75:40-6
pubmed: 27005575
Support Care Cancer. 2016 Apr;24(4):1697-707
pubmed: 26423617
Cancer Nurs. 2011 May-Jun;34(3):238-49
pubmed: 21116175
BMJ. 2009 Oct 13;339:b3410
pubmed: 19826172
BMJ. 2008 Aug 29;337:a1331
pubmed: 18757996
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Clin Med. 2021 Apr 18;10(8):
pubmed: 33919571
Breast Cancer Res Treat. 2010 Jun;121(2):421-30
pubmed: 19771507
Psychooncology. 2015 Oct;24(10):1295-1302
pubmed: 26110777
N C Med J. 2014 Jul-Aug;75(4):283-6
pubmed: 25046097
Thorax. 2015 Mar;70(3):244-50
pubmed: 25323620
Complement Ther Clin Pract. 2015 Feb;21(1):7-10
pubmed: 25697379
Med Sci Sports Exerc. 2009 Apr;41(4):935-46
pubmed: 19276838
Cancer. 2015 Aug 15;121(16):2821-30
pubmed: 25891302
Eur Urol. 2014 May;65(5):856-64
pubmed: 24113319
Bone Marrow Transplant. 2010 Feb;45(2):355-62
pubmed: 19597418
Breast Cancer Res Treat. 2018 Feb;168(1):79-93
pubmed: 29139007
Bone Marrow Transplant. 2009 May;43(9):725-37
pubmed: 19234513
Eur J Haematol. 2011 Aug;87(2):148-56
pubmed: 21545527
Ann Oncol. 2014 Nov;25(11):2237-2243
pubmed: 25096607
Eur J Oncol Nurs. 2013 Jun;17(3):331-9
pubmed: 23084254
Bone Marrow Transplant. 2011 Sep;46(9):1245-55
pubmed: 21132025
Stat Med. 2021 Jan 30;40(2):451-464
pubmed: 33105517
J Strength Cond Res. 2021 May 1;35(5):1350-1356
pubmed: 33677463
Support Care Cancer. 2014 Jan;22(1):95-101
pubmed: 23995813
J Clin Epidemiol. 2011 Feb;64(2):163-71
pubmed: 20688472
Cancer Nurs. 2011 Mar-Apr;34(2):E1-13
pubmed: 20697267
Gynecol Oncol. 2011 Sep;122(3):618-24
pubmed: 21689848
Anticancer Res. 2015 Oct;35(10):5623-9
pubmed: 26408735
Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):647-57
pubmed: 21335510
Cell Metab. 2016 Mar 8;23(3):554-62
pubmed: 26895752
Psychooncology. 2009 Apr;18(4):360-8
pubmed: 19242916
Psychooncology. 2019 Jul;28(7):1367-1380
pubmed: 30838697
BMC Med. 2015 Oct 29;13:275
pubmed: 26515383
Med Clin (Barc). 2016 Sep 16;147(6):262-6
pubmed: 27040178
Support Care Cancer. 2012 Dec;20(12):3169-77
pubmed: 22526147
Syst Rev. 2017 Apr 12;6(1):79
pubmed: 28403893
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Int J Nurs Pract. 2021 Apr;27(2):e12883
pubmed: 32827200
J Ovarian Res. 2013 Apr 04;6(1):21
pubmed: 23557323
J Cancer Surviv. 2023 Aug;17(4):1171-1183
pubmed: 34841461
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Ann Surg Oncol. 2022 Mar;29(3):1839-1850
pubmed: 34725764
Geburtshilfe Frauenheilkd. 2013 Apr;73(4):311-317
pubmed: 24771916
Public Health Rep. 1985 Mar-Apr;100(2):126-31
pubmed: 3920711
Oncol Nurs Forum. 2013 Sep;40(5):E374-81
pubmed: 23989030
Support Care Cancer. 2010 May;18(5):591-9
pubmed: 19609570
Cancers (Basel). 2021 Jan 12;13(2):
pubmed: 33445739
Cancer. 2016 Oct 15;122(20):3166-3174
pubmed: 27332968
Support Care Cancer. 2010 Oct;18(10):1329-39
pubmed: 19834744
Pol Arch Intern Med. 2017 Jan 10;127(1):25-35
pubmed: 28075422
Integr Cancer Ther. 2013 Jul;12(4):291-300
pubmed: 23766391
Integr Cancer Ther. 2015 Sep;14(5):409-18
pubmed: 25917814
J Cancer Surviv. 2012 Dec;6(4):420-30
pubmed: 22836201
Integr Cancer Ther. 2013 May;12(3):213-24
pubmed: 22801943
Cancer. 2013 May 1;119(9):1690-8
pubmed: 23355182
Psychooncology. 2006 Oct;15(10):891-7
pubmed: 16374892
Breast Cancer Res Treat. 2010 Nov;124(1):163-75
pubmed: 20734132
J Surg Res. 2017 Mar;209:30-36
pubmed: 28032568
Public Health. 2016 Jul;136:126-32
pubmed: 27161493
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD008465
pubmed: 22895974
Eur J Phys Rehabil Med. 2010 Dec;46(4):481-7
pubmed: 21224783
Yonsei Med J. 2008 Jun 30;49(3):443-50
pubmed: 18581595
Clin Rehabil. 2010 Jul;24(7):614-22
pubmed: 20530651
J Clin Oncol. 2018 Aug 1;36(22):2297-2305
pubmed: 29894274
J Cancer Surviv. 2020 Oct;14(5):720-730
pubmed: 32594450
BMC Med Res Methodol. 2015 Jul 31;15:58
pubmed: 26227148
Support Care Cancer. 2012 Feb;20(2):267-77
pubmed: 21207071
BMJ. 2001 Jul 14;323(7304):101-5
pubmed: 11451790
Head Neck. 2013 Aug;35(8):1178-88
pubmed: 22847995
Eur J Cancer Care (Engl). 2016 Sep;25(5):784-94
pubmed: 26593858
Indian J Med Res. 2013 Mar;137(3):515-20
pubmed: 23640558
Eur J Cancer Care (Engl). 2003 Dec;12(4):347-57
pubmed: 14982314
Bone Marrow Transplant. 2004 Mar;33(5):553-8
pubmed: 14716346
J Cancer Surviv. 2013 Dec;7(4):551-62
pubmed: 23749688
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
J Cancer Surviv. 2013 Sep;7(3):413-24
pubmed: 23604998
Circulation. 2019 May 21;139(21):e997-e1012
pubmed: 30955352
Cancer. 2014 Jan 15;120(2):294-301
pubmed: 24122296
J Clin Oncol. 2014 Apr 1;32(10):1058-65
pubmed: 24590636
BMJ. 2007 Mar 10;334(7592):517
pubmed: 17307761
Support Care Cancer. 2004 Nov;12(11):774-9
pubmed: 15338385
Breast Cancer Res Treat. 2015 Sep;153(2):371-82
pubmed: 26293147
PLoS One. 2013 Oct 03;8(10):e76654
pubmed: 24098547